Christopher J. Womack

1.3k total citations
47 papers, 956 citations indexed

About

Christopher J. Womack is a scholar working on Cell Biology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Christopher J. Womack has authored 47 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cell Biology, 13 papers in Pulmonary and Respiratory Medicine and 10 papers in Physiology. Recurrent topics in Christopher J. Womack's work include Muscle metabolism and nutrition (15 papers), Blood properties and coagulation (8 papers) and Cardiovascular and exercise physiology (6 papers). Christopher J. Womack is often cited by papers focused on Muscle metabolism and nutrition (15 papers), Blood properties and coagulation (8 papers) and Cardiovascular and exercise physiology (6 papers). Christopher J. Womack collaborates with scholars based in United States, United Kingdom and Canada. Christopher J. Womack's co-authors include Nicholas D. Luden, Paul R. Nagelkirk, Adam M. Coughlin, Michael Saunders, Leslie I. Katzel, C.W. Elston, Andrew W. Gardner, Alberto R. Yataco, Mary C. Corretti and Michael Martin and has published in prestigious journals such as Cell Metabolism, Clinical Cancer Research and Medicine & Science in Sports & Exercise.

In The Last Decade

Christopher J. Womack

43 papers receiving 916 citations

Peers

Countries citing papers authored by Christopher J. Womack

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Womack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Womack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Womack more than expected).

Fields of papers citing papers by Christopher J. Womack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Womack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Womack. The network helps show where Christopher J. Womack may publish in the future.

Co-authorship network of co-authors of Christopher J. Womack

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Womack. A scholar is included among the top collaborators of Christopher J. Womack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Womack. Christopher J. Womack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Carbohydrate hydrogel beverage provides no additional cycling performance benefit versus carbohydrate alone 2019 ·European Journal of Applied Physiology ·Daniel Baur, (unknown), Michael Saunders, (unknown), Nicholas D. Luden, Christopher J. Womack	12
2	The Effect of the CYP1A2 −163 C > A Polymorphism on Caffeine Metabolism and Subsequent Cycling Performance 2018 ·Gabrielle E. W. Giersch, (unknown), Trent A. Hargens, Nicholas D. Luden, Michael Saunders, (unknown), Christine A. Hughey, Ahmed El‐Sohemy, Christopher J. Womack	22
3	Clinically Viable Gene Expression Assays with Potential for Predicting Benefit from MEK Inhibitors 2016 ·Clinical Cancer Research ·Roz Brant, Alan Sharpe, (unknown), Jonathan R. Dry, Elizabeth A. Harrington, J. Carl Barrett, Nicky Whalley, Christopher J. Womack, Paul D. Smith, Darren Hodgson	17
4	First-in-Human Pharmacokinetic and Pharmacodynamic Study of the Dual m-TORC 1/2 Inhibitor AZD2014 2015 ·Clinical Cancer Research ·Bristi Basu, Emma Dean, M. Puglisi, Alastair Greystoke, Michael Ong, Wendy Burke, (unknown), Graham Bigley, Christopher J. Womack, Elizabeth A. Harrington, Stephen Green, Elisabeth Oelmann, Johann S. de Bono, Malcolm Ranson, Udai Banerji	102
5	Arterial adaptations to training among first time marathoners 2015 ·Cardiovascular Ultrasound ·(unknown), Christopher J. Womack, Nicholas D. Luden, M. Kent Todd	8
6	Leptin, BMI, and a Metabolic Gene Expression Signature Associated with Clinical Outcome to VEGF Inhibition in Colorectal Cancer 2015 ·Cell Metabolism ·Aurélien Pommier, Matthew R. Farren, Bhavika Patel, Mark Wappett, Filippos Michopoulos, Neil R. Smith, Jane Kendrew, (unknown), R. Huby, Catherine A. Eberlein, (unknown), Christopher J. Womack, Paul Smith, Jane Robertson, Shethah Morgan, Susan E. Critchlow, Simon T. Barry	15
7	Cycling Time Trial Performance May Be Impaired by Whey Protein and L-Alanine Intake During Prolonged Exercise 2014 ·International Journal of Sport Nutrition and Exercise Metabolism ·Adam B. Schroer, Michael Saunders, Daniel Baur, Christopher J. Womack, Nicholas D. Luden	10
8	Age and aerobic training status effects on plasma and skeletal muscle tPA and PAI-1 2014 ·European Journal of Applied Physiology ·(unknown), (unknown), Adam M. Coughlin, Paul R. Nagelkirk, Christopher J. Womack, Jeffrey T. Lemmer	15
9	Glucose–Fructose Enhances Performance versus Isocaloric, but Not Moderate, Glucose 2014 ·Medicine & Science in Sports & Exercise ·Daniel Baur, Adam B. Schroer, Nicholas D. Luden, Christopher J. Womack, (unknown), Michael Saunders	29
10	What Are the Biggest Challenges and Opportunities for Biorepositories in the Next Three to Five Years? 2010 ·Biopreservation and Biobanking ·Fay Betsou, David L. Rimm, Peter H. Watson, Christopher J. Womack, Allison Hubel, Robert A. Coleman, (unknown), Sharon F. Terry, Nikolajs Zeps, (unknown), (unknown), Robert E. Hewitt, Gloria D. Elliott	15
11	Restructuring A Sales Force for the Modern Marketplace 2009 ·Analytica Chimica Acta ·Christopher J. Womack	1
12	Challenges in the Testing of Non-Heart-Beating Cadavers for Viral Markers: Implications for the Safety of Tissue Donors 2005 ·Cell and Tissue Banking ·David Padley, Morag Ferguson, Ruth M. Warwick, Christopher J. Womack, Sebastian Lucas, J. Saldanha	18
13	Changes in von Willebrand factor and fibrinolysis following a post-exercise cool-down 2004 ·European Journal of Applied Physiology ·Chad M. Paton, Paul R. Nagelkirk, Adam M. Coughlin, Jamie A. Cooper, Gary A. Davis, Houria I. Hassouna, James M. Pivarnik, Christopher J. Womack	13
14	Temporal Changes in tPA and PAI-1 after Maximal Exercise 2004 ·Medicine & Science in Sports & Exercise ·(unknown), Paul R. Nagelkirk, Adam M. Coughlin, James M. Pivarnik, Christopher J. Womack	22
15	Exercise-Induced Changes in Coagulation and Fibrinolysis in Healthy Populations and Patients with Cardiovascular Disease 2003 ·Sports Medicine ·Christopher J. Womack, Paul R. Nagelkirk, Adam M. Coughlin	87
16	Coagulation and Fibrinolytic Responses to Manual versus Automated Snow Removal 2003 ·Medicine & Science in Sports & Exercise ·Christopher J. Womack, Chad M. Paton, Adam M. Coughlin, Paul R. Nagelkirk, Adam deJong, (unknown), Barry A. Franklin	8
17	Blood lipids of young distance runners: distribution and inter-relationships among training volume, peak oxygen consumption, and body fatness 2001 ·European Journal of Applied Physiology ·Joey C. Eisenmann, Christopher J. Womack, Mathew J. Reeves, James M. Pivarnik, Robert M. Malina	13
18	Endothelial reactivity and cardiac risk factors in older patients with peripheral arterial disease 1999 ·The American Journal of Cardiology ·Alberto R. Yataco, Mary C. Corretti, Andrew W. Gardner, Christopher J. Womack, Leslie I. Katzel	84
19	Personal paper: Disclosure of clinical audit records in law: risks and possible defences 1997 ·BMJ ·Christopher J. Womack, Roger Strand, Michelle Lavin	3
20	Flow cytometry in persistent trophoblastic disease 1988 ·Placenta ·(unknown), Philip Quirke, Christopher J. Womack, Michael Wells, C.W. Elston, G. W. Pennington	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact